Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 3 for:    vx15/2503
Previous Study | Return to List | Next Study

Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
Vaccinex Inc. Identifier:
First received: March 4, 2011
Last updated: August 11, 2014
Last verified: August 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):